Press release
Alzheimers Disease Biomarkers Market Projected to Surpass a Valuation of USD 1.7 Billion by 2031
Alzheimers Disease Biomarkers Market
Get Exclusive PDF Sample Copy of Alzheimer's Disease Biomarkers Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44970&utm_source=OpenPR_Ajay&utm_medium=OpenPR
The prevalence of Alzheimer's disease, often affecting older individuals, is on the rise due to factors such as an aging population and lifestyle-related risks. As a result, there is a growing demand for Alzheimer's disease biomarker testing, which is anticipated to drive market growth in the coming years.
According to data from the Harvard Chan School (2020) and Alzheimer's Society (2022), the global population suffering from dementia is expected to triple over the next 30 years. The risk of developing dementia increases with age, with individuals over the age of 90 being particularly susceptible. Lifestyle factors such as alcohol consumption, physical activity, diet, sleep patterns, social engagement, and mental stimulation also play significant roles in the development of Alzheimer's disease and cognitive decline.
Key findings from the research highlight the importance of cerebrospinal fluid (CSF) biomarkers in predicting disease progression and aiding in clinical decision-making. The immunoassay technique is gaining popularity due to its cost-effectiveness and simplicity, contributing to its anticipated prominent share in the Alzheimer's disease biomarkers market.
Factors driving market growth include the increasing older population, rising prevalence of neurological diseases, and sedentary lifestyles. Regionally, North America is expected to experience notable growth, fueled by the high prevalence of neurological diseases, robust research and development activities, and the presence of key market players. Similarly, Asia Pacific is expected to witness growth due to the rising prevalence of dementia, Parkinson's disease, and Alzheimer's disease.
Key players profiled in the report include Thermo Fisher Scientific, Inc., Enzo Life Sciences, Inc., Merck KGaA, AnaSpec, Inc., Fujirebio, Cell Signaling Technology, Inc., NanoSomiX, Imagilys, 23andMe, Inc., QIAGEN, C₂N Diagnostics, Quanterix, and Quest Diagnostics.
The market segmentation includes various types of biomarkers such as CSF biomarkers, genetic biomarkers, and blood biomarkers, along with different detection techniques and end-users. The regions covered in the report include North America, Europe, Asia Pacific, and the Rest of the World.
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=44970&utm_source=OpenPR_Ajay&utm_medium=OpenPR
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alzheimers Disease Biomarkers Market Projected to Surpass a Valuation of USD 1.7 Billion by 2031 here
News-ID: 3374441 • Views: …
More Releases from Transparency Market Research
Specialty Surfactants Market Outlook 2036: Bio-Based Dominance, 1.9% CAGR Growth …
The global Specialty Surfactants Market reached a valuation of US$ 34.2 Billion in 2025 and is projected to climb to US$ 42.0 Billion by 2036, expanding at a steady CAGR of 1.9% from 2026 to 2036. While the growth rate reflects a mature yet stable industry, the sector continues to witness structural shifts driven by sustainability mandates, innovation in bio-based formulations, and expanding applications across end-use industries.
Asia Pacific accounted for…
Socks Market Size Forecast to USD 102.3 Billion by 2036 with Rising Demand for F …
Socks Market Outlook 2036
The global socks market was valued at US$ 56.7 Bn in 2025 and is projected to reach US$ 102.3 Bn by 2036, expanding at a steady CAGR of 5.5% from 2026 to 2036. Market growth is driven by increasing demand for comfortable and functional apparel, rising fashion consciousness, expanding sports participation, and the rapid growth of e-commerce platforms.
👉 Get your sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=9470
Market…
Qatar Tomato Ketchup Market Expanding at 5.6% CAGR Through 2036 - By Type / By P …
The Qatar Tomato Ketchup Market was valued at US$ 16.7 Bn in 2025 and is projected to reach US$ 30.3 Bn by 2036, expanding at a CAGR of 5.6% from 2026 to 2036. The steady growth trajectory reflects increasing consumption of convenience foods, rising demand from quick-service restaurants (QSRs), and continued innovation in product variants and packaging formats.
Get a concise overview of key insights from our Report in this sample…
Waste-to-Energy Market to Reach US$ 58.8 Billion by 2036 at 6.1% CAGR | Transpar …
The global waste-to-energy (WtE) market is entering a dynamic growth phase as governments and industries intensify efforts to transition toward sustainable waste management and renewable power generation. Waste-to-energy refers to the process of converting municipal solid waste (MSW), agricultural waste, and other refuse into usable forms of energy such as electricity, heat, and fuel through technologies including incineration, gasification, pyrolysis, and anaerobic digestion.
As environmental pressures mount and landfill capacity shrinks,…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
